| Line Item | 2026-03-28 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $811.9M | — | +5.0% |
| Cost of Revenue | $431.1M | — | +3.5% |
| Gross Profit | $380.8M | — | +6.8% |
| R&D Expense | $75.3M | — | -11.2% |
| SG&A Expense | $117.6M | — | +13.8% |
| Operating Income | $141.6M | — | +15.8% |
| Pre-tax Income | $93.2M | — | +30.5% |
| Income Tax | $1.0M | — | -87.8% |
| Net Income | $92.0M | — | +46.3% |
| EPS (Basic) | $0.60 | — | +42.9% |
| EPS (Diluted) | $0.60 | — | +46.3% |
| Line Item | 2026-03-28 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $442.7M | +22.8% | +29.9% |
| Accounts Receivable | $529.5M | +15.4% | — |
| Inventory | $644.4M | +0.2% | -4.0% |
| Current Assets | $1.79B | +9.0% | +6.9% |
| Total Assets | $8.48B | +1.5% | +0.5% |
| Current Liabilities | $555.6M | +13.7% |
| Line Item | 2026-03-28 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $183.0M | — | +30.3% |
| Capital Expenditures | $41.5M | — | -61.6% |
| Investing Cash Flow | -$38.4M | — | +64.5% |
| Financing Cash Flow | -$61.6M | — | -175.0% |
| Free Cash Flow | $141.5M | — | +336.7% |
| +8.4% |
| Long-term Debt | $3.65B | -1.3% | -8.4% |
| Stockholders' Equity | $4.05B | +2.4% | +8.0% |